针对非酒精性脂肪肝炎 (NASH) 和心血管风险降低的新疗法
Tarun Biswas1, Angelica Lehker2, Debabrata Mukherjee3
1Tulip Nursing Home, 96 R,B.C. Road, Kolkata, India.
Cardiovascular & hematological disorders drug targets
|November 20, 2024
概括
非酒精性脂肪肝炎 (NASH) 治疗现在包括FDA批准的resmetirom,在改变生活方式的同时提供一种有效的选择. 一些新的药物疗法正在开发NASH和NAFLD,针对关键疾病机制.
科学领域:
- 肝病学和胃肠道学
- 药理学和药物开发领域
背景情况:
- 非酒精性脂肪肝炎 (NASH) 是一种严重的非酒精性脂肪肝疾病 (NAFLD),以肝炎和细胞损伤为标志.
- 从历史上看,改变饮食和炼等生活方式是NASH的主要治疗方法.
研究的目的:
- 审查NASH和NAFLD的当前和新兴疗法.
- 讨论针对NASH病理生理学的新药疗法.
主要方法:
- 在PubMed,EMBASE和科学网络 (SCI) 数据库中进行全面的文献搜索.
- 包括截至2024年9月15日的研究,使用与NAFLD,NASH,肝炎和肝细胞损伤相关的关键词.
主要成果:
- 美国食品和药物管理局已批准resmetirom用于NASH治疗,提供了一个新的治疗选择.
- 多种药物治疗正在开发中,重点是减肥,胰岛素敏感化和脂质改善.
结论:
- 作为NASH的辅助疗法,Resmetirom代表了一项重大进展.
- 目前对新型NASH治疗的持续研究有望扩大患者的治疗选择.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
536
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
536
Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
59
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
59
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Antianginal Drugs: Nitrates and β-Blockers
522
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
522


